A process separates pure components from a product mixture produced by a one-step dimethyl ether synthesis reactor. The product mixture is scrubbed with pure dimethyl ether followed by scrubbing with aqueous methanol solvent in two absorption columns to reduce CO.sub.2 level and to minimize methanol and dimethyl ether loss with the recovered unconverted synthetic gas. The pure water or aqueous methanol is mixed with the vapor stream of CO.sub.2 separation distillation. Dimethyl ether, methanol and water mixture are separated. A scheme for separation of methanol and water mixture minimizes the size, energy and cost of separation. The process can be cost-effective, energy-efficient, environment-friendly and readily-miniaturized.

A process separates pure components from a product mixture produced by a one-step dimethyl ether synthesis reactor. The product mixture is scrubbed with pure dimethyl ether followed by scrubbing with aqueous methanol solvent in two absorption columns to reduce CO.sub.2 level and to minimize methanol and dimethyl ether loss with the recovered unconverted synthetic gas. The pure water or aqueous methanol is mixed with the vapor stream of CO.sub.2 separation distillation. Dimethyl ether, methanol and water mixture are separated. A scheme for separation of methanol and water mixture minimizes the size, energy and cost of separation. The process can be cost-effective, energy-efficient, environment-friendly and readily-miniaturized.

The instant invention relates to seaweed extract compositions, processes for isolation, isolated active agents, and methods of treating disease, disorders and conditions in a subject, including, reactive oxygen species (ROS)-mediated diseases and diseases mediated through the activation of the Nrf2-ARE (antioxidant response element) pathway, including proliferative diseases and disorders, Alzheimer's disease, stroke, and certain diseases and disorders of aging and associated with aging and exposure, by use of the extracts, compounds, and compositions thereof.

The instant invention relates to seaweed extract compositions, processes for isolation, isolated active agents, and methods of treating disease, disorders and conditions in a subject, including, reactive oxygen species (ROS)-mediated diseases and diseases mediated through the activation of the Nrf2-ARE (antioxidant response element) pathway, including proliferative diseases and disorders, Alzheimer's disease, stroke, and certain diseases and disorders of aging and associated with aging and exposure, by use of the extracts, compounds, and compositions thereof.

Systems and processes disclosed may be used to produce a high purity isobutane stream and a high purity 1-butene stream from mixed C4 streams having disparate starting compositions.

Systems and processes disclosed may be used to produce a high purity isobutane stream and a high purity 1-butene stream from mixed C4 streams having disparate starting compositions.

A purification method of desflurane (difluoromethyl-1,2,2,2-tetrafluoroethyl ether of the formula (1)) includes bringing a mixture containing desflurane and a trihalomethane into contact with a base in the presence of a phase transfer catalyst, thereby decomposing the trihalomethane. By this method, only the trihalometane contained as a by-product in the desflurane is decomposed without causing decomposition of the desflurane, whereby the desflurane is obtained with high purity. ##STR00001##

A purification method of desflurane (difluoromethyl-1,2,2,2-tetrafluoroethyl ether of the formula (1)) includes bringing a mixture containing desflurane and a trihalomethane into contact with a base in the presence of a phase transfer catalyst, thereby decomposing the trihalomethane. By this method, only the trihalometane contained as a by-product in the desflurane is decomposed without causing decomposition of the desflurane, whereby the desflurane is obtained with high purity. ##STR00001##

A purification method of desflurane (difluoromethyl-1,2,2,2-tetrafluoroethyl ether of the formula (1)) includes bringing a mixture containing desflurane and a trihalomethane into contact with a base in the presence of a phase transfer catalyst, thereby decomposing the trihalomethane. By this method, only the trihalometane contained as a by-product in the desflurane is decomposed without causing decomposition of the desflurane, whereby the desflurane is obtained with high purity.

##STR00001##

A purification method of desflurane (difluoromethyl-1,2,2,2-tetrafluoroethyl ether of the formula (1)) includes bringing a mixture containing desflurane and a trihalomethane into contact with a base in the presence of a phase transfer catalyst, thereby decomposing the trihalomethane. By this method, only the trihalometane contained as a by-product in the desflurane is decomposed without causing decomposition of the desflurane, whereby the desflurane is obtained with high purity.

##STR00001##